W celu świadczenia usług na najwyższym poziomie stosujemy pliki cookies. Korzystanie z naszej witryny oznacza, że będą one zamieszczane w Państwa urządzeniu. W każdym momencie można dokonać zmiany ustawień Państwa przeglądarki. Zobacz politykę Cookies
X

News

Recommendation of the President – change in medical technology in the following outpatient specialist care services: 04.21-Destruction of cranial or peripheral nerves by injection of a neurolytic agent; 04.25-Destruction of cranial and peripheral nerves by high-temperature anesthesia (thermolysis); 04.24-Destruction of cranial or peripheral nerves by low-temperature anesthesia (cryolesion, cryoneuroablation)

more...

Opinion of the President – Prevention of urinary incontinence among women aged 30+ in Poznań for the years 2025-2027

more...

Opinion of the President – Health policy program for the early detection of visual impairments in 7-year-old children living in the city of Sieradz

more...

Opinion of the President – Prevention and early detection of visual impairments among children aged 5 living in the municipality of Białe Błota

more...

The Transparency Council meeting 29/2025 on 14 July 2025

more...

Publication AWA

more...

Recommendation of the President – HCU Anamix Infant, HCU Anamix Junior, HCU Cooler, HCU Express, HCU gel, HCU Lophlex, HCU Lophlex LQ

more...

Recommendation of the President – Cibinqo (abrocitinib)

more...

Recommendation of the President – Piasky (crovalimab)

more...

Announcement – TLI effectiveness assessment report

more...

Position of the Transparency Council – HCU Anamix Infant, HCU Anamix Junior, HCU Cooler, HCU Express, HCU gel, HCU Lophlex, HCU Lophlex LQ

more...

Position of the Transparency Council – Acarizax – standardized allergen extract from house dust mites (Dermatophagoides pteronyssinus, Dermatophagoides farina)

more...

Position of the Transparency Council – change in medical technology relating to damage to cranial and/or peripheral nerves

more...

Opinion of the Transparency Council – paclitaxelum

more...

Opinion of the Transparency Council – pazopanibum

more...

Position of the Transparency Council – Piasky (crovalimab)

more...

Position of the Transparency Council – Enhertu (trastuzumab deruxtecan)

more...

Communication of the meeting of Transparency Council No. 26/2025 on 23 June 2025

more...

Communication of the meeting of Transparency Council No. 25/2025 on 16 June 2025

more...

Recommendation of the President – Edarabid (edarawon)

more...

Announcement – publication of a notice on tariffs for guaranteed hospital treatment and outpatient specialist care in the field of female reproductive system diseases

more...

Announcement – publication of a notice on tariffs for guaranteed medical rehabilitation services

more...

Announcement – publication of a notice on tariffs for guaranteed hospital treatment services in the field of nervous system diseases

more...

Tariff Plan for 2026

more...